Current stock page

Catalysts

TXG Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Oct 21, 2026

TXG10x Genomics, Inc.

Healthcare / Biotechnology

Low Priority

Relative Laggard

NeutralEdge 3/10
$75.59+$4.13 (+5.78%)

Latest quote

  • Momentum
    46
  • Value
    34
  • Quality
    59
  • Risk resilience
    38
  • Sentiment
    68
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 5, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 45/100

Momentum 46/100 and sentiment 68/100 before the next covered event.

Recent coverage
5 articles

Updated Oct 21, 2026 · Sentiment 49.11%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 46/100AIQ Edge 3/10 Relative Laggard
Beat rate
75%
3 of 4 reported periods
Average surprise
-18.7%
Across covered historical reports
Latest result
+42.4%
Aug 6, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 5, 2026—-$0.27——$147.3M—
Aug 6, 2026—-$0.24-$0.14+42.4%$146.67M$151.04M
May 7, 2026—-$0.29-$0.10+65.5%$146.41M$150.84M
Feb 12, 2026—-$0.19-$0.13+31.6%$159.65M$166.03M
Nov 6, 2025—-$0.07-$0.22-214.3%$142.5M$149M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
7
Buy
12
Hold
12-month analyst target
$64.16
-15.12% versus current price
Based on 10 analyst observations. Targets are estimates, not predictions.
Low target
$22.00
-70.90% vs latest price
Average target
$64.16
-15.12% vs latest price
High target
$110.00
+45.52% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 5, 2026

Next known earnings or reporting date.

EPS estimate-$0.26

Current analyst expectation for the upcoming report.

Revenue estimate$147.96M

Current analyst expectation for the upcoming report.

Sentiment score68

News pressure around the setup.

Momentum score46

Where event reaction would show up first.

AIQ score45/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
10
Average target
$64.16
Target upside
-15.12%
Target range
$22.00 - $110.00
90-day revisions
43

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
5
Neutral
0
Negative
0
gurufocus.com · Oct 16, 2026

A Look at 10x Genomics Inc (TXG) After 3.5% Decline -- GF Value $18.31 vs Price $69.86

On October 16, 2026, 10x Genomics Inc (TXG) shares fell 3.5%, bringing the current price to $69.86. The stock has experienced significant price fluctuations, wi

gurufocus.com · Oct 13, 2026

TXG Maintained by TD Cowen -- Price Target Raised to $70.00

On October 12, 2026, TD Cowen maintained a 'Hold' rating for 10x Genomics (TXG), with a significant price target increase from $47.00 to $70.00, reflecting a 48

gurufocus.com · Oct 13, 2026

TXG Maintained by Morgan Stanley -- Price Target Raised to $70

On October 12, 2023, 10x Genomics (TXG) received an Equal-Weight rating from Morgan Stanley analyst Tejas Savant, who has raised the price target from $40.00 to

gurufocus.com · Oct 12, 2026

10x Genomics Inc (TXG) Shares Fall 6.8% -- What GF Score of 57 Tells Investors

On October 12, 2026, 10x Genomics Inc (TXG) shares fell 6.8% to $75.19, continuing a downward trend that has seen the stock decline 23.1% over the past week. Ov

gurufocus.com · Oct 5, 2026

A Look at 10x Genomics Inc (TXG) After 4.5% Gain -- GF Value $18.33 vs Price $97.74

On October 05, 2026, 10x Genomics Inc (TXG) shares rose 4.5% to a current price of $97.74, significantly up from a 52-week low of $11.16 and near its 52-week hi

Open full news and sentiment

TXG Catalysts FAQ

What are the next catalysts for TXG stock?

TXG's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move TXG stock?

Upcoming events that could move TXG include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could TXG's next earnings report affect the stock?

TXG's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive TXG stock higher?

TXG could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt TXG stock?

TXG could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.